Oxford, UK based OMass Therapeutics announced a $310M series C today, advancing its small molecule platform, including the lead MC2 (melanocortin-2) receptor antagonist that is in phase 1
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
At Dana-Farber Cancer Institute in Boston, President & CEO Ben Ebert and Professor and Investigator Cigall Kadoch discuss the latest trends in cancer research
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Eli Lilly Chairman & CEO David Ricks discusses GLP-1's, Alzheimer's, business development and more
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
After a busy time in Boston during the Aging Research and Drug Discovery Meeting, Insilico Medicine CEO Alex Zhavoronkov discusses the latest in longevity therapeutics and Insilico's pipeline progress
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Monte Rosa Therapeutics announced data for MRT-8102, its NEK7-directed molecular glue degrader, showing positive impact on biomarkers linked to atherosclerotic cardiovascular disease
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From Basel: TOLREMO Therapeutics is working on cancer resistance - the company believes is targeting CBP/p300 just stared phase 1 data at World Lung
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From Basel: Forty51 Ventures was formed in Basel four years ago and has a company building model - they look globally, but believe that having the pharma company pipeline in Basel is an advantage
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From Basel: With two products on the market with momentum and a key pipeline asset in a P3, Basilea has become a world leader in the development of therapies for bacterial and fungal infections
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa succeeded on its primary endpoint of helping patients to see better on low luminance visual acuity in a phase three study
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: BlossomHill IPO'd last month to tackle precision oncology, with a Scientific Founder / CEO who already has a hall of fame record in the space - Jean Cui walks us through her programs
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: As it approaches a BLA filing for its viral immunotherapy in prostate cancer, Candel has published its pivotal phase 3 data in Lancet Oncology and presented extended data at AUA
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: H.C. Wainwright & Co. Senior Biotech Analyst Andres Maldonado shares his take on the latest in oncology
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: InflaRx designed izicopan from the start with the goal of having a differentiated, best in class profile vs the first marketed C5aR inhibitor. Now more than ever this could be opportune
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: GENFIT has developed a blood based test for MASH - its CEO believes the MASH market has arrived. "If you believe in Mash, you have to believe in a diagnostic."
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: Scribe Therapeutics, which represents the next generation of CRISPR, had its IPO in July - the first clinical program targets PCSK9
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: With a $6B valuation, three approved products, up to $700M in revenue guidance this year, and a sizable acquisition under its belt, Mirum has become a rare disease leader
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: With an in-human proof of concept in hand from a rare condition, Prime Medicine is ready to go broader in new indications
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: H.C. Wainwright & Co.'s Managing Director of Healthcare Investment Banking James Cappuccio says that smaller biotech companies are now able to do large raises for the first time in a while
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 26: H.C. Wainwright Senior Biotechnology Analyst Mitchell Kapoor touches on current biotech sentiment, the cardiovascular space, in vivo CAR-T, and a pancreatic study to watch
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 26: Ovid Therapeutics CEO Meg Alexander highlights big progress the company has been making in neuroscience on its next-generation GABA-aminotransferase inhibitor and oral KCC2 direct activator
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: H.C. Wainwright & Co.'s Vice Chair and President of Capital Markets Richard Gormley believes the elements (M&A, IPOs opening up, other financing opportunities) are still ripe for biotech
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: Innate Pharma announced a deal with Sobi last month that will move lacutamab towards a registration filing - their partner Astra also has a huge readout coming soon for monalizumab
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: Trevi Therapeutics was founded under the premise that cough is a brain problem, not a lung problem - it seems to be playing out in the clinic
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: Two key recent papers have validated the use of pramipexole in depression - Alto Neuro believes it has a combination therapy that can make it more tolerable and therefore even better
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
HCW 2026: Switzerland based Oculis focuses today on neuro-ophthalmology, which has led them to a pivotal trial in optic neuritis and key mid-stage data coming this year in dry eye disease
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Bay Area based Shennon Biotechnologies announced a new CEO today, Cyril Konto, and a $12M raise to advance its T-cell engager programs
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
UC Berkeley's Gokul Upadhyayula and Eric Betzig are building AI to interpret detailed movies of living cells captured by their MOSAIC microscope
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Bay Area based Moonwalk Biosciences announced a $70M series B today to advance its adipose-targeted RNAi therapies for obesity and cardiometabolic diseases
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Cloverleaf Bio, a spinout out of Yale, announced $33M in seed financing today that will help it advance its work on a tRNA platform in oncology
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Pareto Securities Healthcare Conference: Sedana Medical's inhaled sedative drug/device combo is currently in front of FDA - they hope to change the ICU with it
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Pareto Securities Healthcare Conference: Pareto's Dan Akschuti highlights the innovation coming out of the Nordics region and companies that have filings in front of FDA
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Congressman Jake Auchincloss discusses the economic impact of biotech, global competition, and efforts he is taking to solidify funding, modernize regulation, and keep the United States on top
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Pareto Securities Healthcare Conference: BioInvent believes that it has found the next big checkpoint in TNFR2 - this summer they had data both in solid and liquid tumors
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Pareto Securities Healthcare Conference: Orexo believes that nasal delivery is superior to other modalities for most uses - they plan to file their naloxone program with FDA immanently
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Pareto Securities Healthcare Conference: Hansa Biopharma has a December 19 PDUFA date with FDA for its IgG depleting therapy that hopes to make more patients eligible for kidney transplant
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Pareto Securities Healthcare Conference: Mendus' cellular immunotherapy has been making progress in numerous cancers - being thoughtful about the setting and goal of treatment have been keys
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
A focus on cutting edge science and a busy year of presentations and partnerships has made Circio not just one of the fastest growing biotech companies in the Nordic region, but in all of Europe
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Sweden's BioArtic founded the science behind the Alzheimer's medicine Leqembi - 2026 has been busy with a Parkinson's program and a host of partnerships for it brain transporter technology advancing
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Remix Therapeutics announced earlier this summer plans to go public via a reverse merger - it's on the back of clinical data that was presented for its RNA modulator at ASCO
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Two fathers of children with rare diseases talk about starting biotech companies to try to create new therapies for their family members and others
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
LifeMine Therapeutics announced a $263M raise today to help accelerate the development of its novel calcineurin activation inhibitor that aims to radically change the profile of organ transplants
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
U.S. Science Summit: Biotech veteran Harvey Berger presents an overview of the history of Kendall Square and what is at stake to keep it a leader in life sciences
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
U.S. Science Summit: Patient perspectives with sickle cell patient advocate Jimi Olaghere and cystic fibrosis advocate Bob Coughlin
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
U.S. Science Summit: Curie.Bio Chairman Alexis Borisy and Parabilis Medicines CEO Mathai Mammen discusses the funding environment for biotech and communicating their work to the public
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
U.S. Science Summit: Flagship Pioneering Founder & CEO Noubar Afeyan discusses his early days in Cambridge and the opportunities it afforded him, science communication, immigrants, and more
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
U.S. Science Summit: "Who will shape the future of Bio?" with Recursion President & CEO Najat Khan
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
U.S. Science Summit: Three science communicator social media all-stars share their stories and offer advice on how to tell science stories that resonate with a broad audience
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
U.S. Science Summit: BiotechTV's Science Correspondent Chloe Kirk introduces the audience to the science communicator social media all-stars who were in attendance at the summit
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
U.S. Science Summit: Listen to BiotechTV founder Brad Loncar's opening remarks at the inaugural U.S. Science Summit
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
U.S. Science Summit: Three leading biotech CEOs share the latest on biotech innovation and discuss how the United States can stay on top of an increasingly competitive global landscape
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
U.S. Science Summit: Dr. Elias Zerhouni discusses the source of what made the United States strong in medical research decades ago and what is at stake to keep supporting it today
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
ASCO 2026: Fresh off an IPO, Eikon Therapeutics Chairman & CEO Roger Perlmutter describes the scientific idea behind the company, and walks us through the leading programs
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
ASCO 2026: "The results that we presented from the RASolute 302 trial are unprecedented." - The CEO behind this year's pancreatic cancer breakthrough walks us through the full results and implications
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
London based Cytospire Therapeutics has announced an $83M series A financing to develop first-in-class pan-gamma delta T-cell engagers - the lead program is an EGFR targeting solid tumors
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Replimune's Chairman discusses FDA's polarizing decision to not approve the company's melanoma treatment after a new review. He says they have filed a FOIA request to learn more about FDA's process
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Invivyd develops monoclonal antibodies to prevent or treat infectious diseases. This approach could be useful in tamping down the measles outbreaks that have been occurring due to under-vaccination
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Bay Area based Epia Neuro exited stealth earlier this month with the goal of developing a device implanted in the skull that could act as an interface to a glove to helps stroke survivors regain grip
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Peter Hotez discusses tropical disease, the importance of science communication, career advice for young scientists, and more
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Physican and Biotech Investor Adam May reacts to this morning's 52 week Rezpeg data in alopecia from Nektar
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
10x Genomics today is announcing Atera, its new in situ spatial transcriptomics platform
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Is this analyst the world's biggest bear on the weight loss space? After downgrading Lilly to a sell rating, HSBC's Rajesh Kumar discusses why he thinks pricing factors are being under-appreciated
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Raymond James Biotech Innovation Symposium: Biotech analyst Tiago Fauth shares his read on the mood of investors and discusses companies he covers
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Raymond James Biotech Innovation Symposium: Korro Bio CEO Ram Aiyer discussed how the company has chosen new RNA editing programs to move forward with this year
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Raymond James Biotech Innovation Symposium: Dyne's CEO John Cox shares an overview of the company's recent landmark DMD data
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Raymond James Biotech Innovation Summit: Checking in with Vera's Founder & CEO Marshall Fordyce ahead of the July 7 FDA decision date for the APRIL & BAFF targeting IgAN treatment Atacicept
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Raymond James Biotech Innovation Symposium: Akebia's CEO John Butler shares an update on the launch of Vafseo and discusses two of the company's pipeline programs
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Raymond James Biotech Innovation Symposium: Wave Life Sciences CEO Paul Bolno discusses the recent INHBE data and previews alpha-1 antitrypsin deficiency data being presented next month
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Raymond James Biotech Innovation Symposium: Tectonic Therapeutic develops biologics against GPCR targets - and is making headway on an unmet need for pulmonary hypertension in heart failure patients
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Raymond James Biotech Innovation Symposium: Eupraxia has a novel extended release platform for - with data already out and more on the way later this year, Eosinophilic Esophagitis has been a good PoC
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Raymond James Biotech Innovation Symposium: Septerna is developing oral small molecules that target GPCRs, it now has two programs in the clinic
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Raymond James Biotech Innovation Symposium: Raymond James analyst Chris Raymond shares his take on biotech and companies he covers
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Harbinger Health is announcing its emphasis on a new category of cancer screening tests today, RESOLVE, that are meant to be used upon the suspicion of cancer symptoms to speed diagnosis and treatment
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Spyre Therapeutics announced today that SPY001, an extended half-life α4β7, showed a 40% clinical remission rate at 12 weeks in moderate-to-severe UC
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Alloy Therapeutics announced a deal with Biogen today to help them discover antisense therapeutics using Alloy's ASO platform. Alloy Founder & CEO Errik Anderson fills us in at the company's R&D Day.
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
The new CEO of Stoke Therapeutics, Ian Smith, discusses Stoke Therapeutics' Dravet syndrome therapy, which caught much attention after publishing phase 1/2 data in NEJM last month
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Iambic's CEO Tom Miller discusses the company's approach to AI drug discovery (hint: it's way more than protein folding), and highlights the company's clinical HER2 program, and two others on the way
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Already this year Chai Discovery has raised a $130M series B and struck a discovery partnership with Eli Lilly - Co-Founder Jack Dent describes how Chai is using AI to design antibodies
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
CellCentric has kicked off dosing of its first registration-supporting study for the oral p300/CBP inhibitor inobrodib in multiple myeloma today
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Coya Therapeutics' CEO Arun Swaminathan discusses the company's focus on harnessing T-regs to treat neurodegenerative diseases
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
RBC Biotech Analyst Leo Timashev shares his take on the sector and discusses companies he covers that are in the news
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Solid Biosciences CEO Bo Cumo discusses recent DMD data for the company's microdystrophin gene therapy, and explains the development and regulatory steps ahead
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Christian Tidona's BioMed X and Michal Preminger are launching BioMed X Venture Labs in Cambridge, MA to create 'build to solve' startups with partners
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Apogee Therapeutics' CEO Michael Henderson discusses today's 52 week maintenance data for the company's extended-dose IL-13 inhibitor it atopic dermatitis
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Biotech CEOs discuss the importance of culture, getting through challenging times, their policy wishlist, and how they are proud of the ways our industry gives back
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From London: Yellowstone Biosciences is leveraging an Oxford AML patient biobank to develop an HLA Class II platform of T-cell engagers
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From London: Edward Hodgkin is the Executive Chair of Syncona's 'Slingshot', a platform that takes early stage science from academic labs that isn't ready to be a company and helps matures it
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From London: Purespring Therapeutics is developing a gene therapy that is delivered locally to the podocytes in the kidney and aims to treat IgAN as its initial indication
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From London: Resolution Therapeutics is in the clinic with its engineered regenerative macrophage therapy to treat end stage liver disease
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From London: With science from the Francis Crick Institute, ALTx Therapeutics launched with £12.55m last month to target cancers that rely on the Alternative Lengthening of Telomeres (ALT)
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From London: iOnctura is developing its allosteric PI3Kδ for uveal melanoma - an indication that has seen progress but still has much unmet need
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From London: Spur Therapeutics is an a phase 3 for its gene therapy for Gaucher Disease - using a unique construct that allows them to have a lower dose than other gene therapies
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From London: Beacon Therapeutics has a phase 3 trial scheduled to read this year for its gene therapy for X-Linked Retinitis Pigmentosa (XLRP)
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
From London: Syncona CEO Chris Hollowood discusses the firm's public and private funds, and the state of investing in life sciences today from the firm's Capital Markets Day
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Checking in with Menlo Ventures' Partner Greg Yap to get his take on the latest trends in AI in healthcare
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Earli, which raised $105M in two rounds, is developing 'Cancer-Activated Promoters' that are set off by cancer-specific transcription factors and turn tumor cells into therapeutic payload factories
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Barclays Miami: MannKind CEO Michael Castagna shares an update on the company, including a recent $360M acquisition, and two regulatory reviews at FDA that have decision dates over the coming months
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Barclays Miami: Barclays' Senior Biotech Analyst Etzer Darout shares his take on biotech and discusses companies he covers that have been in the news
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Barclays Miami: Zealand Pharma CEO Adam Steensberg makes the case for last week's amylin data
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Barclays Miami: Barclays' Head of Healthcare M&A shares his take on the current environment of dealmaking
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Reunion Neuroscience recently received Breakthrough Therapy Designation from FDA for its psychedelic based treatment for postpartum depression (PPD)
Playlist
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.